Sintx Technologies (NASDAQ:SINT – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations.
Profitability
This table compares Sintx Technologies and KORU Medical Systems’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sintx Technologies | -358.79% | -140.68% | -78.29% |
| KORU Medical Systems | -37.42% | -24.60% | -16.87% |
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Sintx Technologies and KORU Medical Systems, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sintx Technologies | 0 | 0 | 0 | 0 | 0.00 |
| KORU Medical Systems | 0 | 1 | 3 | 1 | 3.00 |
Volatility & Risk
Sintx Technologies has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500.
Insider & Institutional Ownership
18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 0.0% of Sintx Technologies shares are owned by insiders. Comparatively, 25.6% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares Sintx Technologies and KORU Medical Systems”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sintx Technologies | $1.64 million | 2.46 | -$8.26 million | ($50.56) | -0.06 |
| KORU Medical Systems | $33.65 million | 3.84 | -$13.74 million | ($0.12) | -23.42 |
Sintx Technologies has higher earnings, but lower revenue than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
KORU Medical Systems beats Sintx Technologies on 12 of the 15 factors compared between the two stocks.
About Sintx Technologies
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
